Drug Master Files for: IBANDRONATE SODIUM
✉ Email this page to a colleague
IBANDRONATE SODIUM Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
15429 | I | II | 5/15/2001 | ROCHE DIAGNOSTICS GMBH | IBANDRONATE, EDITION I |
20391 | A | II | 3/31/2007 | CHONGQING SHENGHUAXI PHARMACEUTICAL CO LTD | SODIUM IBANDRONATE |
20393 | A | II | 3/29/2007 | AUROBINDO PHARMA LTD | IBANDRONATE SODIUM (NON-STERILE DRUG SUBSTANCE) |
20411 | A | II | 4/5/2007 | NATCO PHARMA LTD | IBANDRONATE SODIUM MONOHYDRATE |
20422 | A | II | 4/9/2007 | ORCHID PHARMA LTD | IBANDRONATE SODIUM |
20427 | A | II | 4/5/2007 | CHEMI SPA | SODIUM IBANDRONATE MONOHYDRATE |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information